Limiting Damage during Infection: Lessons from Infection Tolerance for Novel Therapeutics

Open Access

Essays articulate a specific perspective on a topic of broad interest to scientists.

Pedro F. Vale ,

* E-mail: pedro.vale@ed.ac.uk

Affiliations Centre for Immunity, Infection, and Evolution, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom, Institute of Evolutionary Biology, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom
⨯
Andy Fenton,

Affiliation Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom
⨯
Sam P. Brown

Affiliations Centre for Immunity, Infection, and Evolution, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom, Institute of Evolutionary Biology, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom
⨯

Reader Comments (0)

Pathogens
Is the Subject Area "Pathogens" applicable to this article?

Thanks for your feedback.
Virulence factors
Is the Subject Area "Virulence factors" applicable to this article?

Thanks for your feedback.
Toxins
Is the Subject Area "Toxins" applicable to this article?

Thanks for your feedback.
Infectious disease control
Is the Subject Area "Infectious disease control" applicable to this article?

Thanks for your feedback.
Evolutionary immunology
Is the Subject Area "Evolutionary immunology" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Emerging infectious diseases
Is the Subject Area "Emerging infectious diseases" applicable to this article?

Thanks for your feedback.
Antiviral therapy
Is the Subject Area "Antiviral therapy" applicable to this article?

Thanks for your feedback.